Premium
New tool to tackle Alzheimer's disease: amyloid‐β protofibril‐selective antibody Ab SL
Author(s) -
Molnár Elek
Publication year - 2017
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/jnc.14240
Subject(s) - neurochemistry , antibody , amyloid (mycology) , amyloid β , neuroscience , disease , alzheimer's disease , medicine , chemistry , neurology , biology , pathology , immunology
This Editorial highlights a study by Colvin et al . (2017) in the current issue of Journal of Neurochemistry, in which the authors describe the development and characterisation of a new rabbit antibody (termed antibody St. Louis; AbSL) that preferentially recognises amyloid‐β (Aβ) protein 42 (Aβ42) protofibrils over other Aβ species.